Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Oligosaccharide (Monofer) in CKD Patients Requiring Parenteral Iron
2007-000765-37Phase 3Completed
- Sponsor
- Pharmacosmos
- Start
- Mar 2007
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ferric derisomaltose in chronic kidney disease (CKD) and iron deficiency anemia (IDA), sponsored by Pharmacosmos. Primary endpoint: Adverse events. Started Mar 2007; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
chronic kidney disease (CKD)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2007-000765-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000765-37.